Faura, Júlia
Heeman, Bavo
Pottier, Cyril
Baker, Matthew C.
DeJesus-Hernandez, Mariely
Küçükali, Fahri
Heiß, Laura
Wynants, Sarah
Van den Broeck, Marleen
De Rijk, Peter
De Pooter, Tim
Joris, Geert
Finch, NiCole A.
Asmann, Yan
Strazisar, Mojca
Murray, Melissa E.
Petrucelli, Leonard
Oskarsson, Björn
Sleegers, Kristel
Josephs, Keith A.
Nguyen, Aivi T.
Reichard, R. Ross
Petersen, Ronald C.
Boeve, Bradley F.
Graff-Radford, Neill R.
Dickson, Dennis W.
van Blitterswijk, Marka
Rademakers, Rosa
Funding for this research was provided by:
Association for Frontotemporal Degeneration (2022-001)
Bijzonder Onderzoeksfonds UAntwerp, Belgium (BOF 49758)
National Institutes of Health (P50 AG016574, P50 AG016574, P50 AG016574, P50 AG016574, P50 AG016574, P50 AG016574, P50 AG016574, P50 AG016574, P50 AG016574, RF1 NS123052, R35 NS097261)
Office of the Assistant Secretary of Defense for Health Affairs (W81XWH-21-1-07-12)
Vlaams Instituut voor Biotechnologie
Article History
Received: 28 March 2025
Revised: 23 May 2025
Accepted: 26 May 2025
First Online: 6 June 2025
Declarations
:
: RR receives invention royalties from a patent related to progranulin. KAJ is an Associate Editor of Annals of Clinical and Translational Neurology. KAJ, KS and RR are associated editors at Acta Neuropathologica. The rest of the authors have no competing interests to declare that are relevant to the content of this article.
: This study was approved by the University of Antwerp and Mayo Clinic Institutional Review Boards. The collection of tissue samples was approved by the Mayo Clinic Institutional Review Board. All autopsies were obtained after consent by the legal next-of-kin or someone legally authorized to make this decision. Autopsies are performed with the explicit assumption that the tissue will be used for both diagnostic evaluation and research.